Ares Management Corporation

Analysis of ARES Corporation

Technical Outlook ARES is in a pronounced downtrend, having fallen sharply over one and three-month periods while underperforming the broader market. Though currently trading near the midpoint of its 52-week range, the steep decline suggests the stock is oversold. However, with high volatility and a significant maximum drawdown, any recovery may be uncertain and volatile.

Fundamental Health The company shows strong revenue growth but faces severe profitability compression, with net margins shrinking considerably. While liquidity appears adequate and debt servicing is manageable, the very low return on equity signals inefficiency in utilizing shareholder capital. These mixed fundamentals point to operational challenges despite top-line resilience.

Valuation & Risk Assessment Valuation metrics are concerning, with a high trailing P/E and an extreme forward P/E indicating weak near-term earnings expectations. The stock’s high beta and history of deep drawdowns underscore its speculative nature. Without clear peer comparisons, it’s difficult to justify the premium multiples, suggesting elevated risk relative to potential reward.

Investment Recommendation Based on the analysis, ARES is not a recommended buy at this time. The combination of negative technical momentum, deteriorating profitability, and demanding valuation multiples presents significant downside risk. Investors should wait for clearer signs of operational improvement and valuation stabilization before considering a position. For those with high risk tolerance, any potential entry should be approached with caution and tight risk management.

*Note: This is not investment advice, for reference only.*

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, the 12-month outlook for ARES is cautious with a high degree of uncertainty. Key catalysts for a potential recovery would be clear evidence of operational improvement, specifically a reversal in the trend of severe profitability compression and a demonstration of more efficient capital utilization. The primary risks are the continuation of the negative technical momentum, failure to improve weak near-term earnings, and the stock's high volatility potentially leading to further significant drawdowns. Given the lack of an analyst target and the "not recommended" rating, a definitive target price range cannot be established; the path is more likely to be determined by the company's ability to address its fundamental challenges.

Wall Street Consensus

Most Wall Street analysts are optimistic about Ares Management Corporation's 12-month outlook, with consensus target around $133.97, indicating expected upside potential.

Overall, ARES has investment potential but also faces challenges. Here are key factors to weigh before investing.

ARES has delivered significantly negative performance with substantial price declines across multiple timeframes. The stock exhibits high volatility while trading considerably below its annual peak.

Short-term performance has been notably weak with ARES falling 23.09% over one month and 15.25% over three months. The stock has substantially underperformed the broader market by approximately 15.23% during this period, reflecting high beta characteristics.

Currently trading at $130.41, ARES sits roughly 33% above its 52-week low but 33% below its yearly high, positioning it in the middle range of its annual spectrum. Given the recent steep declines, the stock appears oversold despite remaining substantially below its recent highs due to the severe maximum drawdown of -37.1% over the past year.

Revenue & Profitability ARES demonstrated strong revenue growth, increasing from $1.66 billion in Q3 to $1.77 billion in Q4 2025. However, profitability saw significant compression, with the net profit margin declining from 17.4% to 3.1% due to higher operating expenses and a substantial increase in other expenses. The operating profit margin also fell from 21.1% to 29.3%, indicating pressure on core earnings.

Financial Health While specific debt ratios are not provided, the interest coverage ratio of 2.78 suggests the company can service its debt obligations, albeit with moderate cushion. The cash per share of $6.78 indicates solid liquidity, though the absence of current ratio data limits a full assessment of short-term financial stability.

Operational Efficiency ARES shows weak operational efficiency with a return on equity of just 0.63%, reflecting minimal profitability relative to shareholder equity. The asset turnover ratio is unavailable, but the low ROE points to challenges in effectively leveraging assets or equity to generate earnings.

Based on the available metrics, ARES appears significantly overvalued. The TTM P/E of 30.14 is high for most asset management or financial services firms, but the extreme forward P/E of 164.72 suggests collapsing near-term earnings expectations. Further supporting a premium valuation are the very high EV/EBITDA of 89.2 and a negative PEG ratio, which together indicate investor expectations for future growth are disconnected from current profitability.

A conclusive peer comparison cannot be provided as industry average data is unavailable. However, the valuation multiples presented—particularly the exceptionally high forward P/E and EV/EBITDA—would typically be considered at the extreme upper end for financial companies. Without industry benchmarks, it is difficult to determine if these levels are justified by sector-specific growth prospects or represent a clear premium.

Of course. Here is a risk analysis for ARES based on the provided metrics.

The stock exhibits significant volatility risk relative to the broader market. With a Beta of 1.524, ARES is theoretically over 50% more volatile than the market index, meaning it tends to experience sharper price swings both upwards and downwards. This elevated volatility is corroborated by a substantial one-year maximum drawdown of -37.1%, indicating a pronounced history of significant peak-to-trough declines that would test investor risk tolerance.

Based on the provided data, the risk profile lacks the typical pressure from short sellers, as there is no reported short interest. However, the absence of short interest does not eliminate other potential risks. The analysis is notably limited without key metrics such as liquidity (e.g., average trading volume), valuation levels, or the company's fundamental financial health, which are critical for a comprehensive assessment of its operational and market risks.